[go: up one dir, main page]

DE69827240D1 - Verfahren zur herstellung von eprosartan - Google Patents

Verfahren zur herstellung von eprosartan

Info

Publication number
DE69827240D1
DE69827240D1 DE69827240T DE69827240T DE69827240D1 DE 69827240 D1 DE69827240 D1 DE 69827240D1 DE 69827240 T DE69827240 T DE 69827240T DE 69827240 T DE69827240 T DE 69827240T DE 69827240 D1 DE69827240 D1 DE 69827240D1
Authority
DE
Germany
Prior art keywords
eprosartan
producing
producing eprosartan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69827240T
Other languages
English (en)
Other versions
DE69827240T2 (de
Inventor
Robert Flisak
Li Liu
S Labaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE69827240D1 publication Critical patent/DE69827240D1/de
Publication of DE69827240T2 publication Critical patent/DE69827240T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DE69827240T 1997-02-14 1998-02-13 Verfahren zur herstellung von eprosartan Expired - Lifetime DE69827240T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3819597P 1997-02-14 1997-02-14
US38195P 1997-02-14
PCT/US1998/002412 WO1998035963A1 (en) 1997-02-14 1998-02-13 Process for preparing eprosartan

Publications (2)

Publication Number Publication Date
DE69827240D1 true DE69827240D1 (de) 2004-12-02
DE69827240T2 DE69827240T2 (de) 2005-10-13

Family

ID=21898583

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69827240T Expired - Lifetime DE69827240T2 (de) 1997-02-14 1998-02-13 Verfahren zur herstellung von eprosartan

Country Status (41)

Country Link
US (1) US6172237B1 (de)
EP (1) EP0970073B1 (de)
JP (1) JP4537499B2 (de)
KR (1) KR100573638B1 (de)
CN (1) CN1085208C (de)
AP (1) AP1128A (de)
AR (1) AR011125A1 (de)
AT (1) ATE280765T1 (de)
AU (1) AU730383B2 (de)
BG (1) BG63804B1 (de)
BR (1) BR9808664A (de)
CA (1) CA2281708C (de)
CO (1) CO4950550A1 (de)
CY (1) CY2555B1 (de)
CZ (1) CZ296349B6 (de)
DE (1) DE69827240T2 (de)
DK (1) DK0970073T3 (de)
EA (1) EA001659B1 (de)
EG (1) EG23935A (de)
ES (1) ES2231963T3 (de)
HU (1) HU228781B1 (de)
ID (1) ID23181A (de)
IL (1) IL131309A (de)
IN (2) IN187999B (de)
MA (1) MA24470A1 (de)
MY (1) MY118704A (de)
NO (1) NO317194B1 (de)
NZ (1) NZ337180A (de)
OA (1) OA11146A (de)
PE (1) PE59299A1 (de)
PL (1) PL192838B1 (de)
PT (1) PT970073E (de)
RO (1) RO119719B1 (de)
SA (1) SA98190082B1 (de)
SI (1) SI0970073T1 (de)
SK (1) SK285036B6 (de)
TR (1) TR199901936T2 (de)
TW (1) TW399050B (de)
UA (1) UA54487C2 (de)
WO (1) WO1998035963A1 (de)
ZA (1) ZA981207B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100137613A1 (en) * 2006-12-27 2010-06-03 Hetero Drugs Limited Process for eprosartan
WO2009013760A2 (en) * 2007-07-25 2009-01-29 Hetero Drugs Limited Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan
EP2295430A3 (de) * 2007-07-25 2011-08-03 Hetero Drugs Limited Kristalliner Feststoff von Eprosartanacetat
WO2009084028A2 (en) * 2007-12-03 2009-07-09 Neuland Laboratories Ltd Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate
CN101215284B (zh) * 2007-12-31 2010-10-13 浙江华海药业股份有限公司 一种改进的依普罗沙坦的制备方法
US20110054186A1 (en) * 2008-03-31 2011-03-03 Hetero Research Foundation Process for eprosartan intermediate
WO2010023688A2 (en) * 2008-08-25 2010-03-04 Matrix Laboratories Limited An improved process for the preparation of eprosartan
WO2011004384A2 (en) 2009-06-05 2011-01-13 Glochem Industries Limited Process for the preparation of eprosartan
WO2011051975A1 (en) 2009-10-30 2011-05-05 Matrix Laboratories Ltd An improved process for the preparation of pure eprosartanand its pharmaceutical acceptable salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
AU9137791A (en) * 1990-12-14 1992-07-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
NZ285588A (en) * 1994-05-20 1997-12-19 Smithkline Beecham Corp [2-butyl-3-(4-carboxybenzyl)-1h-imidazolium-4-yl]-hydroxymethyl sulphonate

Also Published As

Publication number Publication date
IL131309A0 (en) 2001-01-28
AR011125A1 (es) 2000-08-02
IN192743B (de) 2004-05-15
BG63804B1 (bg) 2003-01-31
CO4950550A1 (es) 2000-09-01
NO317194B1 (no) 2004-09-13
IN187999B (de) 2002-08-03
CY2555B1 (en) 2008-07-02
SI0970073T1 (en) 2005-02-28
ID23181A (id) 2000-03-23
CN1085208C (zh) 2002-05-22
OA11146A (en) 2003-04-16
RO119719B1 (ro) 2005-02-28
NO993913L (no) 1999-08-13
BG103650A (en) 2000-06-30
WO1998035963A1 (en) 1998-08-20
CZ285299A3 (cs) 2000-02-16
BR9808664A (pt) 2000-07-11
ATE280765T1 (de) 2004-11-15
ZA981207B (en) 1998-11-12
DE69827240T2 (de) 2005-10-13
CA2281708C (en) 2007-08-14
EP0970073A1 (de) 2000-01-12
NZ337180A (en) 2000-11-24
SK285036B6 (sk) 2006-05-04
ES2231963T3 (es) 2005-05-16
AU6150898A (en) 1998-09-08
PT970073E (pt) 2005-02-28
TW399050B (en) 2000-07-21
MY118704A (en) 2005-01-31
SA98190082B1 (ar) 2006-08-20
HUP0001994A2 (hu) 2001-06-28
JP4537499B2 (ja) 2010-09-01
NO993913D0 (no) 1999-08-13
TR199901936T2 (xx) 2000-04-21
EG23935A (en) 2008-01-14
AU730383B2 (en) 2001-03-08
US6172237B1 (en) 2001-01-09
HU228781B1 (en) 2013-05-28
HUP0001994A3 (en) 2001-07-30
EA001659B1 (ru) 2001-06-25
PL335075A1 (en) 2000-04-10
EP0970073A4 (de) 2001-01-24
PL192838B1 (pl) 2006-12-29
CA2281708A1 (en) 1998-08-20
PE59299A1 (es) 1999-09-09
UA54487C2 (uk) 2003-03-17
EP0970073B1 (de) 2004-10-27
KR20000071007A (ko) 2000-11-25
CN1247539A (zh) 2000-03-15
MA24470A1 (fr) 1998-10-01
JP2001510466A (ja) 2001-07-31
KR100573638B1 (ko) 2006-04-26
DK0970073T3 (da) 2005-02-21
CZ296349B6 (cs) 2006-02-15
AP1128A (en) 2002-12-06
SK108799A3 (en) 2000-05-16
EA199900740A1 (ru) 2000-02-28
IL131309A (en) 2002-09-12
AP9901620A0 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
DE69719098D1 (de) Verfahren zur herstellung von citalopram
DE69911398D1 (de) Verfahren zur herstellung von 4-aminodiphenylaminen
DE69913666D1 (de) Verfahren zur herstellung von di-methyl-naphthalinen
DE69816440D1 (de) Verfahren zur herstellung von flurbiprofen-lutschtabletten
ATE339433T1 (de) Verbessertes verfahren zur herstellung von makroliden
DE69816295D1 (de) Verfahren zur herstellung von aromatischem poycarbonat
DE59901552D1 (de) Verfahren zur herstellung von polyalkylenarylaten
DE69825880D1 (de) Verfahren zur herstellung von eprosartan
DE69910995D1 (de) Verfahren zur herstellung von fluorkohlenwasserstoffen
DE69827240D1 (de) Verfahren zur herstellung von eprosartan
DE50001895D1 (de) Verfahren zur herstellung von phosphonomethylglycin
ATE225797T1 (de) Verfahren zur herstellung von oxazaphosphorin-2- aminen
DE69819191D1 (de) Verfahren zur herstellung von pentafluorethan
DE69901192D1 (de) Verfahren zur herstellung von cyclopropanmethylamin
ATE220697T1 (de) Verfahren zur herstellung von polyester
ATE233238T1 (de) Verfahren zur herstellung von 3-acyl-indolen
DE69733152D1 (de) Verfahren zur herstellung von tetrazolylbenzopyranen
DE59802764D1 (de) Verfahren zur herstellung von phosphabenzolverbindungen
DE69806759D1 (de) Verfahren zur herstellung von pentafluorethan
DE59903764D1 (de) Verfahren zur herstellung von phytosqualan
ATA200499A (de) Verfahren zur herstellung von hydroxymethylpyridinen
DE59811807D1 (de) Verfahren zur herstellung von chlorbenzoxazolen
DE69813588D1 (de) Verfahren zur herstellung von 3-ispchromanon
DE59802548D1 (de) Verfahren zur herstellung von webware
DE59805432D1 (de) Verfahren zur herstellung von 2-cyclododecyl-1-propanol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition